Cargando…

GIV is a promising novel poor prognostic factor in liver hepatocellular carcinoma

Numerous studies have implicated Gα-interacting, vesicle-associated protein (GIV) in the development and metastasis of various cancers. However, its role remains unclear in liver hepatocellular carcinoma (LIHC). We aimed to demonstrate the relationship between GIV and LIHC based on The Cancer Genome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Zhenzhen, Sun, Yibin, Wang, Lin, Ma, Sai, Sun, Chunrong, Zhou, Yu, Yang, Guorong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371552/ https://www.ncbi.nlm.nih.gov/pubmed/35960100 http://dx.doi.org/10.1097/MD.0000000000029645

Ejemplares similares

GIV: A Tool for Genomic Islands Visualization
por: Che, Dongsheng, et al.
Publicado: (2013)

Sulfiredoxin‐1 is a promising novel prognostic biomarker for hepatocellular carcinoma
por: Rao, Qian‐Wen, et al.
Publicado: (2020)

Rare Norovirus GIV Foodborne Outbreak, Wisconsin, USA
por: Barclay, Leslie, et al.
Publicado: (2021)

GIV/Girdin is a central hub for pro-fibrogenic signalling networks during liver fibrosis
por: Lopez-Sanchez, Inmaculada, et al.
Publicado: (2014)

Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights
por: Yu, James, et al.
Publicado: (2023)

AUI&GIV: Recommendation with Asymmetric User Influence and Global Importance Value
por: Zhao, Zhi-Lin, et al.
Publicado: (2016)

GIV•Kindlin Interaction Is Required for Kindlin-Mediated Integrin Recognition and Activation
por: Rohena, Cristina, et al.
Publicado: (2020)

Activation of G proteins by GIV-GEF is a pivot point for insulin resistance and sensitivity
por: Ma, Gary S., et al.
Publicado: (2015)

Integrins activate trimeric G proteins via the nonreceptor protein GIV/Girdin
por: Leyme, Anthony, et al.
Publicado: (2015)

The stress polarity pathway: AMPK ‘GIV’-es protection against metabolic insults
por: Ghosh, Pradipta
Publicado: (2017)

GIV/Girdin and Exo70 Collaboratively Regulate the Mammalian Polarized Exocytic Machinery
por: Rohena, Cristina, et al.
Publicado: (2020)

AURKB as a Promising Prognostic Biomarker in Hepatocellular Carcinoma
por: Xiao, Jingchuan, et al.
Publicado: (2021)

Plasma HULC as a Promising Novel Biomarker for the Detection of Hepatocellular Carcinoma
por: Xie, Hui, et al.
Publicado: (2013)

Activation of Gαi3 triggers cell migration via regulation of GIV
por: Ghosh, Pradipta, et al.
Publicado: (2008)

The Gαi-GIV binding interface is a druggable protein-protein interaction
por: DiGiacomo, Vincent, et al.
Publicado: (2017)

Genomics Analyses of GIV and GVI Noroviruses Reveal the Distinct Clustering of Human and Animal Viruses
por: Ford-Siltz, Lauren A., et al.
Publicado: (2019)

Prognostic analysis of RAS-related lncRNAs in liver hepatocellular carcinoma
por: Li, Ding, et al.
Publicado: (2022)

Focal adhesions are foci for tyrosine-based signal transduction via GIV/Girdin and G proteins
por: Lopez-Sanchez, Inmaculada, et al.
Publicado: (2015)

Girdin/GIV regulates collective cancer cell migration by controlling cell adhesion and cytoskeletal organization
por: Wang, Xiaoze, et al.
Publicado: (2018)

DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Song, Danjun, et al.
Publicado: (2020)

Structural basis for activation of trimeric Gi proteins by multiple growth factor receptors via GIV/Girdin
por: Lin, Changsheng, et al.
Publicado: (2014)

Complex roles of the actin‐binding protein Girdin/GIV in DNA damage‐induced apoptosis of cancer cells
por: Chen, Chen, et al.
Publicado: (2020)

Liver-specific lncRNA FAM99A may be a tumor suppressor and promising prognostic biomarker in hepatocellular carcinoma
por: Mo, Meile, et al.
Publicado: (2022)

Ornithine transcarbamylase downregulation is associated with poor prognosis in hepatocellular carcinoma
por: He, Lin, et al.
Publicado: (2019)

FANCI is Associated with Poor Prognosis and Immune Infiltration in Liver Hepatocellular Carcinoma
por: Hou, Yibo, et al.
Publicado: (2023)

Tumor micronecrosis predicts poor prognosis of patients with hepatocellular carcinoma after liver transplantation
por: Wang, Yangyang, et al.
Publicado: (2023)

CRM1, a novel independent prognostic factor overexpressed in invasive breast carcinoma of poor prognosis
por: Yue, Lu, et al.
Publicado: (2018)

Poor Prognostic Biomarker KIAA1522 Is Associated with Immune Infiltrates in Hepatocellular Carcinoma
por: Shi, Yongjie, et al.
Publicado: (2023)

Liver-specific LINC01146, a promising prognostic indicator, inhibits the malignant phenotype of hepatocellular carcinoma cells both in vitro and in vivo
por: Ma, Xiaoyun, et al.
Publicado: (2022)

Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma
por: Huang, Yan-Lin, et al.
Publicado: (2019)

A mid-term assessment of progress towards the immunization coverage goal of the Global Immunization Vision and Strategy (GIVS)
por: Brown, David W, et al.
Publicado: (2011)

TEAD2 as a novel prognostic factor for hepatocellular carcinoma
por: Joo, Jong Seok, et al.
Publicado: (2020)

ITPKA expression is a novel prognostic factor in hepatocellular carcinoma
por: Li, Jianbiao, et al.
Publicado: (2015)

SPC25 overexpression promotes tumor proliferation and is prognostic of poor survival in hepatocellular carcinoma
por: Zhang, Baozhu, et al.
Publicado: (2020)

Gαs promotes EEA1 endosome maturation and shuts down proliferative signaling through interaction with GIV (Girdin)
por: Beas, Anthony O., et al.
Publicado: (2012)

A long isoform of GIV/Girdin contains a PDZ-binding module that regulates localization and G-protein binding
por: Ear, Jason, et al.
Publicado: (2021)

Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinoma
por: Liu, Kun, et al.
Publicado: (2016)

Linc00511 Indicates A Poor Prognosis Of Liver Hepatocellular Carcinoma
por: Hu, Pingan, et al.
Publicado: (2019)

Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma
por: Zheng, Xiufeng, et al.
Publicado: (2022)

Prognostic analysis of hepatocellular carcinoma with macrovascular invasion after liver resection and a successful case of conversion therapy
por: Ji, Mengling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j3de3sotr9e9suku1bthhptcet